We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+9.14%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$6.45B
AUM Growth
+$5.8M
Cap. Flow
-$487M
Cap. Flow %
-7.55%
Top 10 Hldgs %
17.51%
Holding
879
New
59
Increased
152
Reduced
496
Closed
61

Top Buys

Rank Stock Value
1
PH icon
Parker-Hannifin
PH
+$16.8M
2
PWR icon
Quanta Services
PWR
+$16.7M
3
HAS icon
Hasbro
HAS
+$16.3M
4
NXPI icon
NXP Semiconductors
NXPI
+$14.7M
5
RRX icon
Regal Rexnord
RRX
+$13.5M

Sector Composition

Rank Sector Weight
1 Technology 19.42%
2 Healthcare 16.47%
3 Financials 13.82%
4 Industrials 10.74%
5 Consumer Discretionary 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HTT
801
High Templar Tech Ltd
HTT
$370M
$140K ﹤0.01%
+29,800
New +$175K
NGL icon
802
NGL Energy Partners
NGL
$1.94B
$138K ﹤0.01%
12,300
JPS
803
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$138K ﹤0.01%
13,788
SBSW icon
804
Sibanye-Stillwater
SBSW
$6.05B
$135K ﹤0.01%
+13,600
New +$105K
CEPU
805
Central Puerto
CEPU
$2.16B
$111K ﹤0.01%
22,800
+4,700
+26% +$16.9K
PMM
806
Franklin Managed Municipal Income Trust
PMM
$270M
$84K ﹤0.01%
10,500
MFM
807
Aberdeen Municipal Income Fund
MFM
$221M
$71K ﹤0.01%
10,000
FINV
808
FinVolution Group
FINV
$1.17B
$68K ﹤0.01%
25,500
+3,100
+14% +$8.22K
NAGE
809
Niagen Bioscience
NAGE
$256M
$67K ﹤0.01%
15,500
-5,500
-26% -$19.5K
ANIX icon
810
Anixa Biosciences
ANIX
$118M
$57K ﹤0.01%
17,400
BMY.RT
811
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$51K ﹤0.01%
+17,444
New +$45.4K
XYF
812
X Financial
XYF
$193M
$37K ﹤0.01%
7,233
VBIV
813
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$30K ﹤0.01%
+733
New +$16.1K
LUMO
814
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$29K ﹤0.01%
1,189
TEUM
815
DELISTED
Pareteum Corporation
TEUM
$8K ﹤0.01%
+18,283
New +$10.6K
COCP icon
816
Cocrystal Pharma
COCP
$12M
$7K ﹤0.01%
1,208
-134
-10% -$1.34K
AIG icon
817
American International
AIG
$42.5B
-6,564
Closed -$365K
AMLP icon
818
Alerian MLP ETF
AMLP
$12.9B
-2,204
Closed -$102K
AVA icon
819
Avista
AVA
$3.43B
-445,760
Closed -$21.6M
BFH icon
820
Bread Financial
BFH
$4.32B
-2,815
Closed -$290K
BSBR icon
821
Santander
BSBR
$38.2B
-97,301
Closed -$1.01M
BTI icon
822
British American Tobacco
BTI
$136B
-38,205
Closed -$1.41M
CDP icon
823
COPT Defense Properties
CDP
$4.32B
-500,156
Closed -$14.9M
CSGS
824
DELISTED
CSG Systems International
CSGS
-44,456
Closed -$2.3M
CSWC icon
825
Capital Southwest
CSWC
$1.47B
-10,664
Closed -$232K

Similar funds

Segall Bryant & Hamill's Q4 2019 Portfolio in Review

As of Q4 2019, Segall Bryant & Hamill held 879 positions worth $6.45B, up 0.09% from $6.44B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Segall Bryant & Hamill withdrew a net $487M in Q4 2019, closing 61 positions and reducing 496 holdings. Its most notable exit was Avista, an estimated $21.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Segall Bryant & Hamill opened a new position in NexTier Oilfield Solutions Inc. worth $11.3M.

  • Segall Bryant & Hamill's largest Q4 2019 buy was NexTier Oilfield Solutions Inc.: 1,680,626 shares worth $11.3M.
  • Segall Bryant & Hamill added most to Parker-Hannifin in Q4 2019, an estimated $16.8M increase.
  • Segall Bryant & Hamill's biggest Q4 2019 reduction was iShares Russell 2000 Value ETF, cutting an estimated $19.6M.
  • Segall Bryant & Hamill fully exited Avista in Q4 2019, selling an estimated $21.6M.
  • Segall Bryant & Hamill's ten largest holdings make up 18% of its $6.45B portfolio in Q4 2019.
  • Segall Bryant & Hamill opened 59 new positions and closed 61 in Q4 2019.
  • Segall Bryant & Hamill's portfolio value rose 0.09% quarter-over-quarter to $6.45B.

Based on Segall Bryant & Hamill's 13F filing for Q4 2019, filed 11 Feb 2020.